<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 38-year-old man with refractory follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> underwent allogeneic BMT from an HLA-identical sibling donor </plain></SENT>
<SENT sid="1" pm="."><plain>He had <z:hpo ids='HP_0008940'>generalized lymphadenopathy</z:hpo>, <z:hpo ids='HP_0001433'>hepatosplenomegaly</z:hpo> and <z:hpo ids='HP_0002665'>lymphoma</z:hpo> infiltration of the marrow, <z:hpo ids='HP_0000001'>all</z:hpo> of which disappeared within 3 months following transplantation </plain></SENT>
<SENT sid="2" pm="."><plain>Six months post-transplant, progressive <z:hpo ids='HP_0002240'>hepatomegaly</z:hpo> developed in the absence of <z:hpo ids='HP_0001744'>splenomegaly</z:hpo> and <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo>, and he died from <z:hpo ids='HP_0001399'>hepatic failure</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Autopsy disclosed diffuse large B cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of the liver, into which the follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> had transformed </plain></SENT>
<SENT sid="4" pm="."><plain>Future issues to be investigated should include the optimal timing of allogeneic BMT for low-grade <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>